CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors
Ijin Joo, Jung Hoon Kim, Jeong Min Lee, Jin Woo Choi, Joon Koo Han, Byung Ihn Choi
Ultrasonography. 2014;33(1):18-25.   Published online 2013 November 15    DOI: https://doi.org/10.14366/usg.13006

Excel Download

Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors
Ultrasonography. 2013;33(1):18-25   Crossref logo
Link1 Link2

Early Identification of Residual Tumors following Microwave Ablation Using Contrast-Enhanced Ultrasonography in a Rabbit VX2 Liver Cancer Model
BioMed Research International. 2020;2020:1-9   Crossref logo
Link1 Link2 Link3

Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters
PLOS ONE. 2018;13(2):e0192706   Crossref logo
Link1

Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Noninvasive Evaluation of Vascular Disrupting Treatment on Rabbit Liver Tumors
PLoS ONE. 2013;8(12):e82649   Crossref logo
Link1

1442: Pathological Study on Contrast Agent-Enhanced High Intensity Focused Ultrasound Ablation of Rabbit VX2 Liver Tumors
Ultrasound in Medicine & Biology. 2009;35(8):S219   Crossref logo
Link1 Link2

Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study
Journal of Vascular and Interventional Radiology. 2018;29(8):1078-1084   Crossref logo
Link1 Link2

Enhanced antitumor efficacy of a novel vascular disrupting agent (CKD-516) for transarterial infusion therapy in hepatocelluar carcinoma (HCC) model
Journal of Vascular and Interventional Radiology. 2014;25(3):S169   Crossref logo
Link1 Link2

Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound
Tumor Biology. 2014;36(4):2593-2599   Crossref logo
Link1 Link2 Link3 Link4

Intravoxel Incoherent Motion Diffusion-weighted MRI Assessing the Effect of the Vascular Disrupting Agent CA4P on VX2 Liver Tumors in Rabbits
Current Medical Imaging Reviews. 2023;20:   Crossref logo
Link1 Link2 Link3

Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model
Korean Journal of Radiology. 2015;16(5):1029   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Ultrasonography has participated in CrossRef Text and Data Mining service since October 29, 2014.